Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

International Myeloma Workshop highlights and ongoing IMF studies

Share :

IMW 2011

3 - 6 May 2011
Published: 20 May 2011
Views: 6258
Rating:
Save
Prof Thierry Facon - Centre Hospitalier Universitaire, Lille, France
Prof Facon discusses an ongoing study of melphalan-prednisone-thalidomide (MP-T) vs low dose lenalidomide-dexamethasone for 18 cycles or until progressive myeloma. The study includes 1623 patients across 300 centres in various countries and is likely to report in 2012. He also discusses some highlights of the International Myeloma Workshop, Paris, 5th May 2011.

Related Videos

The evolving paradigm in management of Multiple Myeloma
Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
The evolving paradigm in management of Multiple Myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
11 Dec 2023
Relapsed Refractory Multiple Myeloma
Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
Relapsed Refractory Multiple Myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
5 Dec 2023
The evolving paradigm in management of Multiple Myeloma
D Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
The evolving paradigm in management of Multiple Myeloma ( D Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
5 Dec 2023
Haemato-oncological Cancers
Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India
Haemato-oncological Cancers ( Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India )
16 Nov 2023
Multiple myeloma (A cancer arising from plasma cells)
Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal
Multiple myeloma (A cancer arising from plasma cells) ( Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal )
9 Nov 2023
Multiple myeloma (A cancer arising from plasma cells)
Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal
Multiple myeloma (A cancer arising from plasma cells) ( Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal )
9 Nov 2023
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Dr Gabriele Casirati - Dana-Farber Cancer Institute, Boston, USA
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia ( Dr Gabriele Casirati - Dana-Farber Cancer Institute, Boston, USA )
3 Oct 2023
Hodgkin’s and non-Hodgkin’s lymphomas (NHL)
Dr Jose Sandoval Sus - Memorial Healthcare System, Florida, USA
Hodgkin’s and non-Hodgkin’s lymphomas (NHL) ( Dr Jose Sandoval Sus - Memorial Healthcare System, Florida, USA )
8 Jul 2023
Real-world use of brexu-cel shows benefit in R/R mantle cell lymphoma treatment
Dr Nausheen Ahmed - The University of Kansas Cancer, Kansas, USA
Real-world use of brexu-cel shows benefit in R/R mantle cell lymphoma treatment ( Dr Nausheen Ahmed - The University of Kansas Cancer, Kansas, USA )
23 Jun 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation